Knowledge Center

Patent / Aug 04, 2022

Inhaled ivermectin

Authors:
  • Beatriz Fernandes
  • João Henriques
  • Eunice Costa
  • Venkatesh Naini
Source:
US 20220241307

The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Ìý

Also in the Knowledge Center

Related Content

Analytical Characterization

ËÄÉ«AV advanced characterization capabilities of inhalation and nasal products is crucial to determine their safety and efficacy.

Page
Read more

ËÄÉ«AV DMFs at FDA

List of DMFs

Page
Read more

Exclusive partnerships

ËÄÉ«AV has experience of developing and supplying off-patent APIs on an exclusive basis.

Page
Read more